222 related articles for article (PubMed ID: 10669031)
21. Biochemical characterization of two crotamine isoforms isolated by a single step RP-HPLC from Crotalus durissus terrificus (South American rattlesnake) venom and their action on insulin secretion by pancreatic islets.
Toyama MH; Carneiro EM; Marangoni S; Barbosa RL; Corso G; Boschero AC
Biochim Biophys Acta; 2000 Mar; 1474(1):56-60. PubMed ID: 10699490
[TBL] [Abstract][Full Text] [Related]
22. Solution structure of crotamine, a Na+ channel affecting toxin from Crotalus durissus terrificus venom.
Nicastro G; Franzoni L; de Chiara C; Mancin AC; Giglio JR; Spisni A
Eur J Biochem; 2003 May; 270(9):1969-79. PubMed ID: 12709056
[TBL] [Abstract][Full Text] [Related]
23. In vitro antibacterial and hemolytic activities of crotamine, a small basic myotoxin from rattlesnake Crotalus durissus.
Oguiura N; Boni-Mitake M; Affonso R; Zhang G
J Antibiot (Tokyo); 2011 Apr; 64(4):327-31. PubMed ID: 21386851
[TBL] [Abstract][Full Text] [Related]
24. Enzyme-linked immunosorbant assay (ELISA) of size-selected crotalid venom antigens by Wyeth's polyvalent antivenom.
Schaeffer RC; Randall H; Resk J; Carlson RW
Toxicon; 1988; 26(1):67-76. PubMed ID: 3347932
[TBL] [Abstract][Full Text] [Related]
25. Physiological and immunological properties of small myotoxins from the venom of the midget faded rattlesnake (Crotalus viridis concolor).
Ownby CL; Aird SD; Kaiser II
Toxicon; 1988; 26(3):319-23. PubMed ID: 3134753
[TBL] [Abstract][Full Text] [Related]
26. Structural and pharmacological characterization of the crotamine isoforms III-4 (MYX4_CROCu) and III-7 (MYX7_CROCu) isolated from the Crotalus durissus cumanensis venom.
Ponce-Soto LA; Martins-de-Souza D; Marangoni S
Toxicon; 2010 Jul; 55(8):1443-52. PubMed ID: 20206199
[TBL] [Abstract][Full Text] [Related]
27. Crotamine and crotalicidin, membrane active peptides from Crotalus durissus terrificus rattlesnake venom, and their structurally-minimized fragments for applications in medicine and biotechnology.
Falcao CB; Radis-Baptista G
Peptides; 2020 Apr; 126():170234. PubMed ID: 31857106
[TBL] [Abstract][Full Text] [Related]
28. Isolation, characterization and crystallization of a phospholipase A2 myotoxin from the venom of the prairie rattlesnake (Crotalus viridis viridis).
Ownby CL; Colberg TR; White SP
Toxicon; 1997 Jan; 35(1):111-24. PubMed ID: 9028014
[TBL] [Abstract][Full Text] [Related]
29. Intrahippocampal infusion of crotamine isolated from Crotalus durissus terrificus alters plasma and brain biochemical parameters.
Gonçalves R; Vargas LS; Lara MV; Güllich A; Mandredini V; Ponce-Soto L; Marangoni S; Dal Belo CA; Mello-Carpes PB
Int J Environ Res Public Health; 2014 Nov; 11(11):11438-49. PubMed ID: 25380458
[TBL] [Abstract][Full Text] [Related]
30. Potentiation of the toxicity of basic peptides from rattlesnake venoms by sodium acetate.
Allen HR; Tucker RK; Geren CR
Toxicon; 1986; 24(6):553-8. PubMed ID: 3750343
[TBL] [Abstract][Full Text] [Related]
31. Individual venom profiling of Crotalus durissus terrificus specimens from a geographically limited region: crotamine assessment and captivity evaluation on the biological activities.
Lourenço A; Zorzella Creste CF; de Barros LC; Delazari dos Santos L; Pimenta DC; Barraviera B; Ferreira RS
Toxicon; 2013 Jul; 69():75-81. PubMed ID: 23380403
[TBL] [Abstract][Full Text] [Related]
32. Isolation of a crotoxin-like protein from the venom of a South American rattlesnake (Crotalus durissus collilineatus).
Lennon BW; Kaiser II
Comp Biochem Physiol B; 1990; 97(4):695-9. PubMed ID: 2085953
[TBL] [Abstract][Full Text] [Related]
33. Comparison of the immunogenicity and antigenic composition of ten Central American snake venoms.
Anderson SG; Gutiérrez JM; Ownby CL
Toxicon; 1993 Aug; 31(8):1051-9. PubMed ID: 8212043
[TBL] [Abstract][Full Text] [Related]
34. Detection of antibodies to myotoxin a and prairie rattlesnake (Crotalus viridis viridis) venom in three antisera using enzyme-linked immunosorbent assay and immunodiffusion.
Ownby CL; Odell GV; Theakston RD
Toxicon; 1983; 21(6):849-55. PubMed ID: 6419394
[TBL] [Abstract][Full Text] [Related]
35. Intraspecific variation in the venoms of the South American rattlesnake (Crotalus durissus terrificus).
Francischetti IM; Gombarovits ME; Valenzuela JG; Carlini CR; Guimarães JA
Comp Biochem Physiol C Toxicol Pharmacol; 2000 Aug; 127(1):23-36. PubMed ID: 11081410
[TBL] [Abstract][Full Text] [Related]
36. Comparison of the immunogenicity and antigenic composition of several venoms of snakes in the family Crotalidae.
Ownby CL; Colberg TR
Toxicon; 1990; 28(2):189-99. PubMed ID: 2339435
[TBL] [Abstract][Full Text] [Related]
37. Biological versatility of crotamine--a cationic peptide from the venom of a South American rattlesnake.
Kerkis I; Silva Fde S; Pereira A; Kerkis A; Rádis-Baptista G
Expert Opin Investig Drugs; 2010 Dec; 19(12):1515-25. PubMed ID: 21062230
[TBL] [Abstract][Full Text] [Related]
38. Immunological studies with the venom of the scorpion Tityus serrulatus.
Barral-Netto M; Vinhas V; Schriefer A; Barral A; Santos SB; Almeida AR; Novaes G
Braz J Med Biol Res; 1991; 24(2):171-80. PubMed ID: 1823231
[TBL] [Abstract][Full Text] [Related]
39. Crotamine, a small basic polypeptide myotoxin from rattlesnake venom with cell-penetrating properties.
Rádis-Baptista G; Kerkis I
Curr Pharm Des; 2011 Dec; 17(38):4351-61. PubMed ID: 22204433
[TBL] [Abstract][Full Text] [Related]
40. Antileishmanial activity, cytotoxicity and cellular response of amphotericin B in combination with crotamine derived from Crotalus durissus terrificus venom using in vitro and in silico approaches.
Valentim-Silva JR; de Barros NB; Macedo SRA; Ferreira ADS; Silva RS; Dill LSM; Zanchi FB; do Nascimento JR; do Nascimento FRF; Lourenzoni MR; Soares AM; Calderon LA; Nicolete R
Toxicon; 2022 Oct; 217():96-106. PubMed ID: 35977615
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
